Bulletin
Investor Alert

May 21, 2020, 5:34 a.m. EDT

Bollinger's Bullish Stocks: $JNJ $NVO $PM

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    Novo Nordisk A/S ADR (NVO)
  • X
    Philip Morris International Inc. (PM)

or Cancel Already have a watchlist? Log In

May 21, 2020 (The Market Signal via Comtex) -- Sector Reports was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking for stocks to buy /zigman2/quotes/201724570/composite JNJ -0.08% , /zigman2/quotes/203484366/composite NVO -0.26% or /zigman2/quotes/201611010/composite PM +4.02% then we strongly urge you to join our community by signing up with the link below and getting a completely free research report on each company today.

http://www.sectorreports.com.au/lP/?symbol=FREE-REPORT

(Click the link above or copy, paste and hit enter in your browser for your report)

Johnson & Johnson to discontinue the selling of talc-based baby powder

https://www.sectorreports.com.au/landing-page/?symbol=JNJ

(Click the link above or copy, paste and hit enter in your browser for your report)

Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.08% stock currently looks bullish and its 20 Days Bollinger Band $144.87 is below the last trading price. The company has announced that it will discontinue the selling of the talc-based Baby Powder as part of the health conglomerates' reorganization of the products they offer. The company is discontinuing the sale following a decline in talc-based product sales following growing concern that the products can potentially cause cancer.

Also, the company reported positive results from a proof-of-concept study for its bispecific antibody, JNJ-5957 in patients with relapsed multiple myeloma. The company presented the results during the ASCO conference which showed that the antibody can have a significant impact on shrinking tumors in patients that have relapsed after around two to 14 treatment lines.

Novo Nordisk to offer free insulin to patients for 90 days

https://www.sectorreports.com.au/landing-page/?symbol=NVO

(Click the link above or copy, paste and hit enter in your browser for your report)

Novo Nordisk A/S /zigman2/quotes/203484366/composite NVO -0.26% is also looking bullish currently and its 20 Days Bollinger Band $61.93 is below the last trading price. The company has announced that diabetes patients using the Novo Nordisk insulin that has lost their health insurance coverage due to the impact of COVID-19 could be eligible for enrollment in the company's Patient Assistance Program to receive free insulin for 90 days.

Also, the company recently announced that the EU gave marketing approval for oral semaglutide (Rybelsus) which is a treatment for patients with inadequately controlled diabetes II to help enhance glycemic controls as an adjunct to exercise and diet. The company is planning to launch Rybelsus in the second half of this year across the 27 EU states and the UK.

Philip Morris reports Q1 2020 results and withdraws FY2020 earnings forecast

https://www.sectorreports.com.au/landing-page/?symbol=PM

(Click the link above or copy, paste and hit enter in your browser for your report)

Another stock that is currently looking bullish is Philip Morris International Inc. /zigman2/quotes/201611010/composite PM +4.02% whose 20 Days Bollinger Band $66.24 is below the last trading price. The company has reported its Q1 2020 results in which its diluted EPS grew by 34.5% to $1.17 and an increase of 11% in adjusted diluted earnings per share of $1.21. The company declared quarterly dividends of $1.17 per share of its common stock.

The company has however withdrawn its FY 2020 diluted earnings per share forecast citing uncertainties due to the coronavirus pandemic. In Q2 the company expects reported diluted earnings per share of between $1.00 and $1.10.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market, and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

The post Bollinger's Bullish Stocks: $JNJ $NVO $PM appeared first on The Market Signals .

COMTEX_365980298/2662/2020-05-21T05:34:04

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 142.37
-0.12 -0.08%
Volume: 4.28M
July 10, 2020 4:00p
P/E Ratio
22.20
Dividend Yield
2.84%
Market Cap
$375.40 billion
Rev. per Employee
$603,509
loading...
/zigman2/quotes/203484366/composite
US : U.S.: NYSE
$ 65.44
-0.17 -0.26%
Volume: 806,591
July 10, 2020 4:00p
P/E Ratio
25.79
Dividend Yield
1.34%
Market Cap
$153.22 billion
Rev. per Employee
$409,726
loading...
/zigman2/quotes/201611010/composite
US : U.S.: NYSE
$ 72.96
+2.82 +4.02%
Volume: 5.43M
July 10, 2020 4:00p
P/E Ratio
14.87
Dividend Yield
6.41%
Market Cap
$109.22 billion
Rev. per Employee
$382,519
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 142.37
-0.12 -0.08%
Volume: 4.28M
July 10, 2020 4:00p
P/E Ratio
22.20
Dividend Yield
2.84%
Market Cap
$375.40 billion
Rev. per Employee
$603,509
loading...
/zigman2/quotes/203484366/composite
US : U.S.: NYSE
$ 65.44
-0.17 -0.26%
Volume: 806,591
July 10, 2020 4:00p
P/E Ratio
25.79
Dividend Yield
1.34%
Market Cap
$153.22 billion
Rev. per Employee
$409,726
loading...
/zigman2/quotes/201611010/composite
US : U.S.: NYSE
$ 72.96
+2.82 +4.02%
Volume: 5.43M
July 10, 2020 4:00p
P/E Ratio
14.87
Dividend Yield
6.41%
Market Cap
$109.22 billion
Rev. per Employee
$382,519
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.